Latest Funding News

Dragon Mountain Gold Limited reports promising drilling results at its Avalon Project and prepares for further exploration at Cawse, supported by a successful $670,000 capital raise and strategic board appointment.

Percheron Therapeutics has terminated its phase IIb avicursen trial for Duchenne muscular dystrophy after failing to meet efficacy endpoints, while securing $14.85 million in fresh capital to explore new therapeutic opportunities.

Advance Metals Limited has significantly expanded its portfolio with binding agreements to acquire high-grade silver and gold projects in Mexico and Australia, setting the stage for an active 2025 exploration campaign.

Adherium reports strong patient adoption and new US partnerships, positioning for significant expansion in 2025 with a target of 9,000 active users and entry into the Pharmacy Benefit Management sector.

Australian Dairy Nutritionals Limited reports improved cash flow in Q2 FY25 and prepares for the strategic launch of its premium Future brand in China, aiming to reshape its growth trajectory.

Loyal Lithium Limited has consolidated its position in North America’s lithium sector through a key acquisition and promising exploration results, positioning itself strongly for 2025.

Pro-Pac Packaging reported a revenue increase to $73.1 million for Q2 FY25, supported by new financing facilities and a fresh CEO appointment, while navigating cash flow pressures and challenging market conditions.

G11 Resources reports significant copper-rich massive sulphide intersections at its Peveril-Grasmere project, confirming a mineralised zone extending over 1km strike and 500m depth. The company is also advancing strategic reviews for acquisitions complementary to its Koonenberry Project.

Norwood Systems has secured a fifth variation to its cash drawdown facility, increasing the principal to $720,114 and extending repayment to mid-February 2025. The move underscores ongoing financial support from a key director amid evolving capital needs.

Immutep Limited has initiated its pivotal Phase III trial for eftilagimod alfa in first-line non-small cell lung cancer, supported by compelling survival outcomes from ongoing studies and a robust cash position expected to fund operations through 2026.

Axiom Properties Limited reported a $518,000 increase in cash reserves for the December quarter, reaching $1.86 million, while extending key debt facilities to support its Mt Barker development and the rapidly expanding ListSure business.

Vintage Energy Ltd has launched a $2.1 million entitlement offer, issuing 417.3 million new shares and free attaching options to fund a production uplift program targeting scale accumulation in its Southern Flank gas fields.